Workboat Indexes

Qiagen N.V. Common Shares (NY: QGEN )

44.67 +0.35 (+0.79%)

Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Volume	1,788,935
Open	43.84
Bid (Size)	44.11 (1)
Ask (Size)	45.28 (1)
Prev. Close	44.32
Today's Range	43.78 - 44.95
52wk Range	39.03 - 47.44
Shares Outstanding	227,985,334
Dividend Yield	2.96%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data

December 12, 2024

From QIAGEN N.V.

Via Business Wire

QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation

December 05, 2024

From QIAGEN N.V.

Via Business Wire

Performance

YTD	+2.34%	+2.34%
1 Month	+4.42%	+4.42%
3 Month	+0.47%	+0.47%
6 Month	+6.28%	+6.28%
1 Year	+2.78%	+2.78%

More News

QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing

November 28, 2024

From QIAGEN N.V.

Via Business Wire

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

April 29, 2024

Via Benzinga

Earnings Scheduled For February 6, 2024

February 06, 2024

Via Benzinga

Earnings Preview: Qiagen

February 05, 2024

Via Benzinga

Where Qiagen Stands With Analysts

December 07, 2023

Via Benzinga

18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'

October 10, 2024

Via Benzinga

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

August 06, 2024

From Myriad Genetics, Inc.

Via GlobeNewswire

Strategic Buy Lights Up This Biotech Stock: Time to Invest?

July 16, 2024

Via MarketBeat

Analyst Expectations for Qiagen's Future

November 02, 2023

Via Benzinga

FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation

June 24, 2024

Via Benzinga

Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

June 20, 2024

Via Benzinga

Qiagen Unveils Plan For $1B Shareholder Returns, Major Product Launches

June 17, 2024

Via Benzinga

QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications

May 30, 2024

From Myriad Genetics, Inc.

Via GlobeNewswire

Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report

May 06, 2024

Via Benzinga

QGEN Stock Earnings: Qiagen Beats EPS, Beats Revenue for Q1 2024

April 29, 2024

Via InvestorPlace

US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?

April 29, 2024

Via Benzinga

US Stocks Set To Approach New Week With Caution Ahead Of Fed Meeting, Tech Earnings: Analyst Says 'Buy The Dip' Contingent On This Condition

April 29, 2024

Via Benzinga

Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion

January 17, 2024

Via Benzinga

Qiagen's Health Odyssey: Expanding In Riyadh And Partnering In Public Projects

January 03, 2024

Via Benzinga

Qiagen Has Steady Income And Defensive Growth Potential, Goldman Sachs Upgrades Stock

December 07, 2023

Via Benzinga

These Companies Helped The German DAX Index Hit Its All-time High

December 06, 2023

Via Talk Markets

Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends

October 31, 2023

Via Benzinga

Earnings Scheduled For October 30, 2023

October 30, 2023

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.